USA flag logo/image

An Official Website of the United States Government

Chemical Casualty Care: Hydrogel Nanoparticle Aggregates as Wound Dressings…

Award Information

Agency:
Department of Defense
Branch:
Army
Award ID:
74008
Program Year/Program:
2005 / SBIR
Agency Tracking Number:
A052-131-1312
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ACCESS PHARMACEUTICALS, INC.
2600 Stemmons Freeway, Suite 176 Dallas, TX 75207 0210
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2005
Title: Chemical Casualty Care: Hydrogel Nanoparticle Aggregates as Wound Dressings Following Debridement of Cutaneuous Vesicant Injuries
Agency / Branch: DOD / ARMY
Contract: W81XWH-06-C-0026
Award Amount: $69,988.00
 

Abstract:

The proposed research will demonstrate the utility of hydrogel nanoparticle aggregates as bandages for post-debridement vesicant injuries. Dehydrated hydrogel nanoparticles in powder form are applied to the surface of a wound. The nanoparticles aggregate immediately and form a continuous hydrogel film that absorbs exudate and protects the wound surface. Studies show that an aggregate film controls the release of antibiotics, painkillers, protein-based growth factors, and steroids for periods ranging from weeks to months. The research will apply the wound dressing to burns in an animal model and assess the healing and local pharmacokinetics for released therpeutics.

Principal Investigator:

John V. St. John
Senior Scientist
2149055100
jvs@accesspharma.com

Business Contact:

Stephen B. Thompson
Chief Financial Officer
2149055100
sbt@accesspharma.com
Small Business Information at Submission:

ACCESS PHARMACEUTICALS, INC.
2600 Stemmons Freeway, Suite 176 Dallas, TX 75207

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No